<DOC>
	<DOCNO>NCT00711191</DOCNO>
	<brief_summary>This study aim seek evidence activation certain cell immune system safe well tolerate combination cytotoxic chemotherapy . Preliminary evidence clinical anti-tumor activity sought .</brief_summary>
	<brief_title>A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>1stline surgically incurable cancer pancreas ECOG ( Eastern Cooperative Oncology Group ) performance status 01 Previous systemic therapy pancreas cancer History cancerassociated blood clot History autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>pancreas cancer ; cancer pancreas ; gemcitabine ; chemotherapy ; monoclonal antibody ; immunotherapy ; CD40</keyword>
</DOC>